Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
18.99
+0.68 (3.71%)
Feb 26, 2026, 3:18 PM EST - Market open
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $5.36 billion as of February 26, 2026.
Market Cap
5.36B
Enterprise Value
4.94B
1-Year Change
n/a
Ranking
Category
Stock Price
$18.99
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $5.36B, a decrease of -10.02%. That is a compound annual growth rate of -14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 5.17B | -32.13% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 5.71B |
| Immunovant | 5.57B |
| Protagonist Therapeutics | 5.46B |
| CRISPR Therapeutics AG | 5.45B |
| Celcuity | 4.90B |
| Apogee Therapeutics | 4.81B |
| Scholar Rock Holding | 4.80B |
| Structure Therapeutics | 4.76B |